Efficacy of probiotics in preventing atopic dermatitis in infants: A systematic review and meta-analysis

Tianli Wei1, Yingxue Ding1

  • 1Department of Pediatrics, Beijing Friendship Hospital, Capital Medical University, China.

Insights

Probiotic supplementation in infants does not prevent atopic dermatitis. Current evidence does not support routine use for prevention, as benefits seen in other studies involved maternal and infant regimens.

Area of Science:

  • Pediatric Allergy and Immunology
  • Microbiome Research
  • Preventive Medicine

Background:

  • Probiotic modulation of infant gut microbiota is explored for atopic dermatitis prevention.
  • Existing evidence on probiotics for preventing atopic dermatitis in infants is inconsistent.

Purpose of the Study:

  • To systematically review and meta-analyze randomized controlled trials on probiotic supplementation in infants (0-36 months) for atopic dermatitis prevention.
  • To assess the clinical relevance and efficacy of infant-only probiotic use.

Main Methods:

  • Systematic search of PubMed, Web of Science, EMBASE, and Cochrane Library up to January 2026.
  • Inclusion of randomized controlled trials in infants aged 0-36 months comparing probiotics to placebo or no intervention.
  • Risk of bias assessment using Cochrane risk of bias 2 tool and random-effects meta-analysis.

Main Results:

  • Eighteen randomized controlled trials with 10,195 participants were analyzed.
  • No significant protective effect of probiotics against atopic dermatitis was found (Risk Ratio = 0.94; 95% CI: 0.72-1.25).
  • Substantial heterogeneity (I² = 72.8%) was observed; sensitivity analyses confirmed robustness, and no publication bias was detected.

Conclusions:

  • Current evidence does not support routine probiotic supplementation solely during infancy for atopic dermatitis prevention.
  • Positive effects in prior meta-analyses may stem from perinatal (maternal-plus-infant) regimens, not infant-only supplementation.
  • Infant-only probiotic supplementation has not demonstrated consistent preventive benefits for atopic dermatitis.

Related Concept Videos

Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Acne Infection01:27

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...